7AVA

Solution structure of the fluorogen-activating protein FAST in complex with the ligand N871b

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-13C NOESY aromatic	0.85 mM [U-13C; U-15N] FAST, 0.90 mM N87, 20 mM sodium phosphate, 20 mM sodium chloride, 0.01 % sodium azide	95% H2O/5% D2O	40 mM	7.0	1 atm	298	Bruker AVANCE III 800
2	3D 1H-13C NOESY aromatic	0.85 mM [U-13C; U-15N] FAST, 0.90 mM N87, 20 mM sodium phosphate, 20 mM sodium chloride, 0.01 % sodium azide	95% H2O/5% D2O	40 mM	7.0	1 atm	298	Bruker AVANCE III 800
3	3D 1H-15N NOESY	0.85 mM [U-13C; U-15N] FAST, 0.90 mM N87, 20 mM sodium phosphate, 20 mM sodium chloride, 0.01 % sodium azide	95% H2O/5% D2O	40 mM	7.0	1 atm	298	Bruker AVANCE III 800
4	3D HCCH-TOCSY	0.85 mM [U-13C; U-15N] FAST, 0.90 mM N87, 20 mM sodium phosphate, 20 mM sodium chloride, 0.01 % sodium azide	95% H2O/5% D2O	40 mM	7.0	1 atm	298	Bruker AVANCE III 800
5	3D HNCO	0.85 mM [U-13C; U-15N] FAST, 0.90 mM N87, 20 mM sodium phosphate, 20 mM sodium chloride, 0.01 % sodium azide	95% H2O/5% D2O	40 mM	7.0	1 atm	298	Bruker AVANCE III 800
6	3D HNCACB	0.85 mM [U-13C; U-15N] FAST, 0.90 mM N87, 20 mM sodium phosphate, 20 mM sodium chloride, 0.01 % sodium azide	95% H2O/5% D2O	40 mM	7.0	1 atm	298	Bruker AVANCE III 800
7	3D HCCH-TOCSY	0.85 mM [U-13C; U-15N] FAST, 0.90 mM N87, 20 mM sodium phosphate, 20 mM sodium chloride, 0.01 % sodium azide	95% H2O/5% D2O	40 mM	7.0	1 atm	298	Bruker AVANCE III 800
8	3D HCCH-COSY	0.85 mM [U-13C; U-15N] FAST, 0.90 mM N87, 20 mM sodium phosphate, 20 mM sodium chloride, 0.01 % sodium azide	95% H2O/5% D2O	40 mM	7.0	1 atm	298	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
2	chemical shift assignment	CARA		Keller and Wuthrich
3	processing	qMDD		Orekhov, Mayzel
4	data analysis	TALOS-N		Cornilescu, Bax

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.